These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15959425)

  • 1. Electronic pill-boxes in the evaluation of oral hypoglycemic agent compliance.
    Charpentier G; Fleury F; Dubroca I; Vaur L; Clerson P
    Diabetes Metab; 2005 Apr; 31(2):189-95. PubMed ID: 15959425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide.
    Draeger KE; Wernicke-Panten K; Lomp HJ; Schüler E; Rosskamp R
    Horm Metab Res; 1996 Sep; 28(9):419-25. PubMed ID: 8911976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes).
    Kardas P
    Diabetes Obes Metab; 2005 Nov; 7(6):722-8. PubMed ID: 16219016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between plasma leptin and plasma insulin levels in type-2 diabetic patients before and after treatment with glibenclamide and glimepiride.
    Bhattacharya SK; Madan M; Mahajan P; Paudel KR; Rauniar GP; Das BP; Roy RK
    Indian J Physiol Pharmacol; 2008; 52(1):43-52. PubMed ID: 18831351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.
    Dills DG; Schneider J
    Horm Metab Res; 1996 Sep; 28(9):426-9. PubMed ID: 8911977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide.
    Holstein A; Plaschke A; Egberts EH
    Diabetes Metab Res Rev; 2001; 17(6):467-73. PubMed ID: 11757083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of teneligliptin added to glimepiride in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study with an open-label, long-term extension.
    Kadowaki T; Kondo K
    Diabetes Obes Metab; 2014 May; 16(5):418-25. PubMed ID: 24205974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia.
    Holstein A; Plaschke A; Hammer C; Egberts EH
    Eur J Clin Pharmacol; 2003 Jun; 59(2):91-7. PubMed ID: 12698302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Roberts VL; Stewart J; Issa M; Lake B; Melis R
    Clin Ther; 2005 Oct; 27(10):1535-47. PubMed ID: 16330290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of single versus multiple daily doses of glibenclamide in type 2 diabetes mellitus.
    Wan Mohamad WB; Tun Fizi A; Ismail RB; Mafauzy M
    Diabetes Res Clin Pract; 2000 Aug; 49(2-3):93-9. PubMed ID: 10963819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment escalation options for patients with type 2 diabetes after failure of exenatide twice daily or glimepiride added to metformin: results from the prospective European Exenatide (EUREXA) study.
    Schernthaner G; Rosas-Guzmán J; Dotta F; Guerci B; Simó R; Festa A; Kiljański J; Zhou M; Gallwitz B
    Diabetes Obes Metab; 2015 Jul; 17(7):689-98. PubMed ID: 25846577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of glimepiride in type 2 diabetic patients treated with glibenclamide.
    Hamaguchi T; Hirose T; Asakawa H; Itoh Y; Kamado K; Tokunaga K; Tomita K; Masuda H; Watanabe N; Namba M
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S129-32. PubMed ID: 15563963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in patients' body weight after 12 months of treatment with glimepiride or glibenclamide in Type 2 diabetes: a multicentre retrospective cohort study.
    Martin S; Kolb H; Beuth J; van Leendert R; Schneider B; Scherbaum WA
    Diabetologia; 2003 Dec; 46(12):1611-7. PubMed ID: 14600814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group.
    Rosenstock J; Samols E; Muchmore DB; Schneider J
    Diabetes Care; 1996 Nov; 19(11):1194-9. PubMed ID: 8908379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide.
    Massi-Benedetti M; Herz M; Pfeiffer C
    Horm Metab Res; 1996 Sep; 28(9):451-5. PubMed ID: 8911982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus.
    González-Ortiz M; Guerrero-Romero JF; Violante-Ortiz R; Wacher-Rodarte N; Martínez-Abundis E; Aguilar-Salinas C; Islas-Andrade S; Arechavaleta-Granell R; González-Canudas J; Rodríguez-Morán M; Zavala-Suárez E; Ramos-Zavala MG; Metha R; Revilla-Monsalve C; Beltrán-Jaramillo TJ
    J Diabetes Complications; 2009; 23(6):376-9. PubMed ID: 18849173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-lowering effects and low risk of hypoglycemia in patients with maturity-onset diabetes of the young when treated with a GLP-1 receptor agonist: a double-blind, randomized, crossover trial.
    Østoft SH; Bagger JI; Hansen T; Pedersen O; Faber J; Holst JJ; Knop FK; Vilsbøll T
    Diabetes Care; 2014 Jul; 37(7):1797-805. PubMed ID: 24929431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of glimepiride in Japanese type 2 diabetic subjects.
    Inukai K; Watanabe M; Nakashima Y; Sawa T; Takata N; Tanaka M; Kashiwabara H; Yokota K; Suzuki M; Kurihara S; Awata T; Katayama S
    Diabetes Res Clin Pract; 2005 Jun; 68(3):250-7. PubMed ID: 15936468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.